MeAgain Index

MeAgain Index and data featured in

  • Yahoo
  • The Washington Times
  • MarketWatch
  • Inc.

Coming end of January 2027

Q3 2026

Medicare Bridge Launches, and Fall Flavors Arrive

Q2 2026

GLP-1 Pills Take Off, and Classic Meals Get Protein

Q1 2026

Lilly Leads Meds, and Protein Leads Everything Else

Methodology

What is the MeAgain Index?

The MeAgain Index is a quarterly ranking of the Top GLP-1 Brands, Trending GLP-1 Products and Leading GLP-1 Meds. Our proprietary methodology combines real-world data from hundreds of thousands of members on the MeAgain platform with select signals from across the GLP-1 ecosystem.

How the MeAgain Index is calculated

MeAgain's real-world behavior data from hundreds of thousands of users and millions of consumer products is the foundation of the index methodology. We combine this internal data with signals across the wider GLP-1 ecosystem, including product launches, brand and retailer partnerships, clinical trial data, new research, social media trends, demand & visibility in AI channels and third-party reported data. Figures from the MeAgain platform are always adjusted for the growth of our member base. The MeAgain Index methodology is built on three dimensions: Access, Use and Impact as described in depth below.

Access

01Easy to find
Visibility in web search and AI discovery, online access and delivery, and how widely it is stocked at pharmacies and retailers nationwide.
02Easy to understand
Clear and accurate labeling and marketing that show it suits GLP-1 users, with proven claims the everyday consumer can easily understand.
03Easy to buy
Price and affordability (including membership constraints), insurance coverage where it applies, and availability through official channels.

Use

01Interest
In-app, web and AI discovery search volumes, plus conversations on social media and on the MeAgain platform that show initial demand.
02Adoption
How much people consume a product or brand, or how many start a medication, based on real-world observed data.
03Adherence and retention
How consistently people keep consuming a product or brand, or taking a medication, based on real-world observed data.

Impact

01Health outcomes
Functional benefits of products, such as protein or fiber, and weight loss, side effects or other health outcomes driven by medications.
02Quality-of-life improvements
Changes or outcomes that impact daily life, including energy, self-esteem, or relationships.
03Consumer sentiment
Social listening across posts and comments on Reddit, TikTok, Instagram and YouTube, plus ratings, reviews and poll comments on the MeAgain platform.

How to read the rankings

+3
Places up since last quarter
−2
Places down since last quarter
–
Same place as last quarter
New
New to the list this quarter
Dropped out
On last quarter's list, not on this one
Seasonal
A seasonal product

How often the MeAgain Index is published

The MeAgain Index is published every quarter.

A living methodology

We expect the MeAgain Index to keep evolving as the MeAgain platform grows, consumer trends shift and GLP-1 treatment continues to change. We will add new data sources over time. The exact formula used in the MeAgain Index is not disclosed.

For more information about the MeAgain Index please contact index@meagain.com

Coming soon

MeAgain IndexQ4 2026

Leave your email and we'll let you know as soon as the next edition is out.